| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4541185
Max Phase: Preclinical
Molecular Formula: C26H25N3O2
Molecular Weight: 411.51
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: O=C(CCc1ccccc1)NC(Cc1c[nH]c2ccccc12)C(=O)Nc1ccccc1
Standard InChI: InChI=1S/C26H25N3O2/c30-25(16-15-19-9-3-1-4-10-19)29-24(26(31)28-21-11-5-2-6-12-21)17-20-18-27-23-14-8-7-13-22(20)23/h1-14,18,24,27H,15-17H2,(H,28,31)(H,29,30)
Standard InChI Key: QHWZDGRQVAOVSC-UHFFFAOYSA-N
Associated Targets(non-human)
Tumor necrosis factor ligand superfamily member 11/11A 69 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 411.51 | Molecular Weight (Monoisotopic): 411.1947 | AlogP: 4.47 | #Rotatable Bonds: 8 |
| Polar Surface Area: 73.99 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 12.74 | CX Basic pKa: | CX LogP: 4.71 | CX LogD: 4.71 |
| Aromatic Rings: 4 | Heavy Atoms: 31 | QED Weighted: 0.40 | Np Likeness Score: -0.59 |
References
| 1. Jiang M, Peng L, Yang K, Wang T, Yan X, Jiang T, Xu J, Qi J, Zhou H, Qian N, Zhou Q, Chen B, Xu X, Deng L, Yang C.. (2019) Development of Small-Molecules Targeting Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Receptor Activator of Nuclear Factor-κB (RANK) Protein-Protein Interaction by Structure-Based Virtual Screening and Hit Optimization., 62 (11): [PMID:31082234] [10.1021/acs.jmedchem.8b02027] |
Source
Source(1):